The Research and Development team at Glympse Bio focuses on advancing the creation of synthetic biomarkers by leveraging cutting-edge science, engineering, and AI. The team conducts rigorous research and experimentation to synthesize and analyze these biomarkers, ensuring they are highly specific and adaptable to various diseases. Their efforts are crucial for enabling earlier detection and response measurement for patients, ultimately enhancing treatment outcomes.